Drug Type Small molecule drug |
Synonyms |
Mechanism PBRM1 inhibitors(Protein polybromo-1 inhibitors), SMARCA2 inhibitors(Probable global transcription activator SNF2L2 inhibitors), SMARCA4 inhibitors(Transcription activator BRG1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H21N5O2 |
InChIKeyFHRKRGDHMCCDEO-LLVKDONJSA-N |
CAS Registry1997321-20-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Microsatellite Instability cancer | Preclinical | US | 28 Sep 2022 |